Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Benzoxazines as new human topoisomerase I inhibitors and potential poisons.

Foto E, Özen Ç, Zilifdar F, Tekiner-Gülbaş B, Yıldız İ, Akı-Yalçın E, Diril N, Yalçın İ.

Daru. 2019 Dec 12. doi: 10.1007/s40199-019-00315-x. [Epub ahead of print]

2.

The 12th AFMC International Medicinal Chemistry Symposium (AIMECS 2019) in Istanbul, Turkey.

Olgac A, Yalcin I, Aki-Yalcin E.

ChemMedChem. 2020 Jan 7;15(1):162-167. doi: 10.1002/cmdc.201900623. Epub 2019 Nov 14.

PMID:
31724830
3.

4-Thiazolidinone Derivatives as MMP Inhibitors in Tissue Damage: Synthesis, Biological Evaluation and Docking Studies.

Incerti M, Crascì L, Vicini P, Aki E, Yalcin I, Ertan-Bolelli T, Cardile V, Graziano ACE, Panico A.

Molecules. 2018 Feb 14;23(2). pii: E415. doi: 10.3390/molecules23020415.

4.

Biological evaluation and pharmacophore modeling of some benzoxazoles and their possible metabolites.

Zilifdar F, Foto E, Ertan-Bolelli T, Aki-Yalcin E, Yalcin I, Diril N.

Arch Pharm (Weinheim). 2018 Feb;351(2). doi: 10.1002/ardp.201700265. Epub 2018 Jan 23.

PMID:
29359805
5.

Determination of the Apoptotic Effect and Molecular Docking of Benzamide Derivative XT5 in K562 Cells.

Ozkan T, Hekmatshoar Y, Ertan-Bolelli T, Hidayat AN, Beksac M, Aki-Yalcin E, Yalcin I, Sunguroglu A.

Anticancer Agents Med Chem. 2018;18(11):1521-1530. doi: 10.2174/1871520618666171229222534.

PMID:
29298654
6.

Design and synthesis of 2-substituted-5-(4-trifluoromethylphenyl-sulphonamido)benzoxazole derivatives as human GST P1-1 inhibitors.

Ertan-Bolelli T, Bolelli K, Musdal Y, Yildiz I, Aki-Yalcin E, Mannervik B, Yalcin I.

Artif Cells Nanomed Biotechnol. 2018 May;46(3):510-517. doi: 10.1080/21691401.2017.1324464. Epub 2017 May 14.

PMID:
28503938
7.

Prediction of retention characteristics of heterocyclic compounds.

Nesměrák K, Toropov AA, Toropova AP, Yildiz I, Yalcin I, Brozikova M, Klimešová V, Waisser K.

Anal Bioanal Chem. 2015 Dec;407(30):9185-9. doi: 10.1007/s00216-015-9067-6. Epub 2015 Oct 1.

PMID:
26427498
8.

Synthesis and biological evaluation of 2-substituted-5-(4-nitrophenylsulfonamido)benzoxazoles as human GST P1-1 inhibitors, and description of the binding site features.

Ertan-Bolelli T, Musdal Y, Bolelli K, Yilmaz S, Aksoy Y, Yildiz I, Aki-Yalcin E, Yalcin I.

ChemMedChem. 2014 May;9(5):984-92. doi: 10.1002/cmdc.201400010. Epub 2014 Mar 26.

PMID:
24677708
9.

Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.

Ertan T, Yildiz I, Tekiner-Gulbas B, Bolelli K, Temiz-Arpaci O, Ozkan S, Kaynak F, Yalcin I, Aki E.

Eur J Med Chem. 2009 Feb;44(2):501-10. doi: 10.1016/j.ejmech.2008.04.001. Epub 2008 Apr 27.

PMID:
18524419
10.

Some benzoxazoles and benzimidazoles as DNA topoisomerase I and II inhibitors.

Oksuzoglu E, Tekiner-Gulbas B, Alper S, Temiz-Arpaci O, Ertan T, Yildiz I, Diril N, Sener-Aki E, Yalcin I.

J Enzyme Inhib Med Chem. 2008 Feb;23(1):37-42. doi: 10.1080/14756360701342516 .

PMID:
18341251
11.

Synthesis and biological activity of some new benzoxazoles.

Temiz-Arpaci O, Yildiz I, Ozkan S, Kaynak F, Aki-Sener E, Yalçin I.

Eur J Med Chem. 2008 Jul;43(7):1423-31. Epub 2007 Oct 5.

PMID:
18023934
12.

In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis.

Martins M, Schelz Z, Martins A, Molnar J, Hajös G, Riedl Z, Viveiros M, Yalcin I, Aki-Sener E, Amaral L.

Int J Antimicrob Agents. 2007 Mar;29(3):338-40. Epub 2007 Jan 18.

PMID:
17239569
13.

Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.

Ertan T, Yildiz I, Ozkan S, Temiz-Arpaci O, Kaynak F, Yalcin I, Aki-Sener E, Abbasoglu U.

Bioorg Med Chem. 2007 Mar 1;15(5):2032-44. Epub 2006 Dec 24.

PMID:
17223562
15.

Induction of apoptosis and necrosis by resistance modifiers benzazoles and benzoxazines on tumour cell line mouse lymphoma L5718 Mdr+cells.

Varga A, Aki-Sener E, Yalcin I, Temiz-Arpaci O, Tekiner-Gulbas B, Cherepnev G, Molnar J.

In Vivo. 2005 Nov-Dec;19(6):1087-91.

16.

3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular field analysis method.

Temiz-Arpaci O, Tekiner-Gulbas B, Yildiz I, Aki-Sener E, Yalcin I.

Bioorg Med Chem. 2005 Dec 1;13(23):6354-9. Epub 2005 Jun 29.

PMID:
15993083
17.

Synthesis and antimicrobial activity of some 5-[2-(morpholin-4-yl)acetamido] and/or 5-[2-(4-substituted piperazin-1-yl)acetamido]-2-(p-substituted phenyl)benzoxazoles.

Temiz-Arpaci O, Ozdemir A, Yalçin I, Yildiz I, Aki-Sener E, Altanlar N.

Arch Pharm (Weinheim). 2005 Mar;338(2-3):105-11.

PMID:
15765492
18.

Synthesis and antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.

Yildiz-Oren I, Tekiner-Gulbas B, Yalcin I, Temiz-Arpaci O, Aki-Sener E, Altanlar N.

Arch Pharm (Weinheim). 2004 Jul;337(7):402-10.

PMID:
15237391
19.

Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors.

Pinar A, Yurdakul P, Yildiz I, Temiz-Arpaci O, Acan NL, Aki-Sener E, Yalcin I.

Biochem Biophys Res Commun. 2004 Apr 30;317(2):670-4.

PMID:
15063810
20.

A target site for template-based design of measles virus entry inhibitors.

Plemper RK, Erlandson KJ, Lakdawala AS, Sun A, Prussia A, Boonsombat J, Aki-Sener E, Yalcin I, Yildiz I, Temiz-Arpaci O, Tekiner B, Liotta DC, Snyder JP, Compans RW.

Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5628-33. Epub 2004 Mar 31.

Supplemental Content

Loading ...
Support Center